Skip to main content

Umbrella Labs Review: FDA Record, Product Identity and Evidence Limits (2026)

This review separates FDA’s dated Umbrella record from current supplier questions. It does not claim firsthand product testing, current fulfillment verification or a whole-vendor quality score. The distinction between a research compound and a medicine is covered in our guide to FDA approval.

Current lot reports not authenticatedHistorical US addressSARMs & Peptides
By the Peptide Dossier Editorial TeamUpdated How we source

Umbrella Labs: Historical Record and Current Access

The FDA’s May 18, 2021 Umbrella warning letter identifies umbrella.us and related sites including umbrellalabs.is, with a Tucson address in that historical record. It establishes the entity and domains addressed then, not current corporate continuity or today’s warehouse location. Direct retrieval of umbrellalabs.is was unavailable in this review; no order or logged-in record was inspected.

Product Identity: Catalog Labels Are Not Chemical Classes

FDA’s historical letter describes products marketed as SARMs and other research materials. Those marketing categories are not a correct classification for every named molecule. Ibutamoren (MK-677) is a growth-hormone secretagogue, and Cardarine (GW-501516) is a PPARβ/δ agonist; neither should be called a SARM. This review does not establish the current catalog or any material’s treatment suitability.

Testing and Certificates: What Needs Verification

A vendor-wide claim that every batch has independent identity, purity, sterility or contaminant testing needs the actual reports and sample coverage. No current lot report was independently authenticated for this review. Check the exact material, lot identifier, amount, laboratory, method and date, and distinguish seller posting from issuer verification. A certificate does not automatically establish every quality attribute or clinical safety.

Pricing: No Current Comparative Quote

This review does not establish a current item price, volume discount or competitive market tier. Price comparison requires the same material, form, amount, documentation, date and complete charges. A higher price cannot be justified as a quality premium without evidence of the claimed differences.

Shipping and Delivery: Policy vs. Experience

No current shipping policy, order, packaging, delivery or cold-chain test was completed. A claim of US-based shipping needs current records; a historical FDA address does not establish today’s fulfillment arrangements. Obtain destination-specific written terms and distinguish estimated dispatch from documented delivery.

Reputation: Keep Transactions and Assays Separate

No independently examined customer dataset establishes current service quality, repeat-purchase rates or product consistency here. Reviews should be tied to dates, actual items and transactions. A positive testimonial is not an assay, and a negative account is not by itself proof of a business-wide pattern.

What the Available Record Supports

  • A dated FDA record links the named operation and domains to specific marketing and product findings in 2021.
  • Chemical identity can be checked independently of a seller’s catalog category.
  • A useful supplier assessment separates current entity, lot documentation, price and order performance.

What Remains Unresolved

  • Current website retrieval and operator continuity.
  • Current catalog, item-specific prices, shipping and return terms.
  • Authentication and coverage of any current lot reports.
  • Actual fulfillment, support and customer outcomes.

An unresolved question is an evidence limit, not an allegation that a defect, closure or fraud occurred.

Assessment: Regulatory Record, Not a Blanket Vendor Score

FDA’s 2021 letter described unapproved and misbranded drug marketing; research-only wording did not negate the human-use claims the agency cited. A later closeout is not established here. This dated finding does not itself prove current product composition, operation or a whole-vendor quality rating. No purchase recommendation or human-use protocol follows.

Editorial method: this guide synthesizes the linked primary sources and separates program terms from individual eligibility. It does not report firsthand product testing or a clinician review. See our editorial process and corrections contact.

Frequently Asked Questions

Frequently Asked Questions

The available evidence supports a dated regulatory and documentation review, not a blanket legitimacy or product-quality grade. FDA’s May 2021 letter identifies the historical operation and domains; current access and transaction questions remain open.

The historical FDA letter names various research products, but this review does not establish the current catalog. Ibutamoren and Cardarine should not be classified as SARMs merely because a seller groups them with that category.

No current lot report was independently authenticated here. Any testing claim needs the actual sample, lot, laboratory, method and date. Document availability and independent verification are different findings.

Current destination-specific policies and delivery performance were not verified. A historical business address does not establish current shipping location or a delivery guarantee.

No current matched price or volume-discount comparison is established. Compare the same material, form, amount, date, documentation and complete charges rather than inferring value from a vendor label.

No independently examined dataset establishes a current overall reputation rating. Review individual dated transactions separately from analytical product evidence.

Legal status depends on the actual product, intended activity and jurisdiction. Research-only labeling is not a universal exemption, drug approval or a patient-use authorization. A dated agency record should not be extended beyond its stated scope.

Match current entity and domain records, exact product and lot identifiers, laboratory reports and written transaction terms. This review did not authenticate a product or determine a personal treatment option.

Medical & Legal Disclaimer

This article is provided for informational and educational purposes only. Research chemicals are sold "for research purposes only" and not for human consumption. The legal status of research chemicals varies significantly by jurisdiction. Before purchasing, verify local regulations and consult with legal authorities if necessary.

This review does not constitute medical advice, professional recommendation, or endorsement. Individuals considering any research compounds should consult with qualified healthcare professionals, understand potential risks, and comply with all applicable laws. Peptide Dossier is not responsible for misuse, illegal activity, or adverse outcomes resulting from use of these products.

Vendor practices, product quality, and availability change over time. Public sources were checked October 27, 2026; the 2021 letter remains historical and current-site retrieval was unavailable. Verify current vendor information before making purchasing decisions.

For context on publisher interests and source limitations, read our disclosures